Asia Digital Healthcare Innovation Summit 2023

-会议内容-

Background 

COVID-19 has ushered in a new wave of healthcare innovations from technological adoption to regulatory updates across the pharma and medical device industry in Asia.

In this summit, we bring you the latest insights and expert perspectives on how pharma and medical device can keep up with digital health;how they can create patient-centered digital health innovations; and how they can activate new business segments via digital health to drive business digital growth.

Hot Points

1.Patient-centric Digital Healthcare 

What are the roles of enterprises, platforms, doctors and institutions in patient-centric healthcare model? How to better serve patients? How to build a comprehensive medical ecosystem integrating medical service, pharmaceutics, medical insurance and patient? How to innovate patient management mode?

2.Digital Therapeutics

What is digital therapeutics? How can digital therapeutics bring value to different parties in the industry? How to implement digital therapeutics?

3.HCP Engagement Innovation

Transformative technologies like HCP engagement management deliver a solution that integrates with existing IT ecosystems. How to have better business processes while adhering to compliance regulations?

4.Pricing and Market Access

Increasingly, payers, providers and regulators are looking at new types of data and evidence when evaluating price and value - especially for innovative products. Understanding how these stakeholders define value, which evidence data matters, and where your portfolio may face risk around the world is an essential element in Asia market access strategy to protect and expand commercial success.

5.Digital Marketing

What’s the impact of COVID-19 on the Asia digital marketing in pharma market? What value can digital marketing bring to enterprises?

6.Healthcare Regulations

As regulations governing pharma and medical devices and technology continue to evolve around the world. How can we protect patient privacy and use regulatory intelligence to meet the compliance goals?

-主办方介绍-

上海希为投资管理有限公司(ECV international)

上海希为投资管理有限公司(ECV international)于2010年在中国上海成立，是一家专门从事国际高端会议策划及承办的公司。我们为已经拥有或计划开发中国市场的外资企业提供专业的商业及管理咨询服务，主要致力于行业的智能、绿色及可持续发展等问题。我们通过与政府相关部门以及行业协会等机构的合作，成功举办了一些具有行业影响力的高端国际性会议，并且和许多跨国企业建立多次合作关系。通过我们持续的热情和卓绝的努力，和我们的客户一起创造价值。 公司文化：创造价值，追求卓越 我们的愿景:成为值得信赖的且能为客户创造价值的合作伙伴。